Nature Communications · 2018 · 182 citations · 54 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesTranscriptional RegulationCancer Cell SignalingOncogene ActivationOncogene MutationsOncogenic Signaling PathwaysProtein Kinase CascadesSignal Transduction In CancerBraf V600 MutationsBraf V600e MutationCancer Signaling PathwaysCooperative Oncogenic Signaling PathwaysFos OncogenesOncogenic Braf SignalingTert Promoter MutationsTumor Promoter Mechanisms
The unique oncogene duet of coexisting BRAF V600E and TERT promoter mutations are widely found to be a robust genetic background promoting human cancer aggressiveness, but the mechanism is unclear. Here, we demonstrate that the BRAF V600E/MAP kinase pathway phosphorylates and activates FOS, which in turn acts as a transcription factor to bind and activate the GABPB promoter, increasing GABPB expression and driving formation of GABPA-GABPB complex; the latter selectively binds and activates mutant TERT promoter, upregulating TERT expression. Elevated TERT functions as a strong oncoprotein, robustly promoting aggressive behaviors of cancer cells and tumor development. We thus identify a molecular mechanism for the activation of mutant TERT by the BRAF V600E/MAP kinase pathway, in which FOS as a transcriptional factor of GABPB promoter plays a key role in functionally bridging the two oncogenes in cooperatively promoting oncogenesis, providing important cancer biological and clinical implications.
54
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations
Highly Recurrent <i>TERT</i> Promoter Mutations in Human Melanoma
Franklin W. Huang, Eran Hodis, Mary Jue Xu et al. · Science · 2013 · 1.8K citations · Full text